Exploring the present to provide you with the keys to the future

Publications - 19 10月 2022

Post-filing data and inventive step (case G2/21): the EPO’s Enlarged Board of Appeal gives its preliminary opinion

By

Publications - 19 10月 2022

Protection of inventions relating to a dosage or administration regimen in China: possible but only in some cases

By

Publications - 23 9月 2022

IP considerations for cell-therapies

By

Publications - 17 5月 2022

Accelerating examination to obtain a US patent

Publications - 31 3月 2022

Whether or not to opt out of the competence of the unified patent court: another issue for european patent owners

By

Publications - 01 3月 2022

European patent with unitary effect: soon it will be time to choose !

By

Publications - 18 2月 2022

CRISPR/Cas9: a nebula of patents

By

Publications - 19 1月 2022

The European Patent with Unitary Effect and the Unified Patent Court will come into being in 2022

By

Publications - 30 12月 2021

Protecting by patent a drug combining two known active ingredients: is it possible ?

By

Publications - 23 12月 2021

Dosage or administration regimens are patentable in Japan, but inventive step may be tricky!

By

Publications - 02 12月 2021

American and French Patent Offices Enter into a PPH Agreement

Publications - 25 11月 2021

Continuing applications : pointers for european applicants on creating US patent portfolio